February 28, 2011 — The US Food and Drug Administration (FDA) has approved guanfacine extended-release tablets (Intuniv, Shire Plc) as adjunctive therapy to stimulants such as methylphenidate in ...

Oral use of guanfacine by children and adolescents newly diagnosed with attention-deficit/hyperactivity disorder (ADHD) increases corneal aberrations but does not ...